Funding
Undisclosed · Biotech

Gero raises $17m with Melnichek Investments backing

The financing backs physics-based AI drug discovery using longitudinal human data.

Updated Oct 16, 2026By RoundOS Funding desk

Gero raised $17 million in financing on June 17, with participation from Melnichek Investments. The company combines physics-based AI and longitudinal human data to discover drugs targeting aging and age-related diseases.

Funding history

Undisclosed · This round$17M

Sources

  1. Geroprojectstartups.com
  2. businesswire.com

Similar rounds

All Biotech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Knowledge Work

Tokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.

¥4.8BSeries C debt second close · Oct 23, 2026

Related